High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study.
作者： F. Fagioli , M. Aglietta , A. Tienghi , S. Ferrari , A. Brach del Prever
关键词:
摘要: … disease and one of toxicity. Transplantation-related mortality was 3.1%. The relapse or progression disease … The 3-year overall survival rate is 20% and the 3-year disease-free survival …
elsevier.com
jco.org参考文章(46)
S. Ferrari, V. Sassoli, M. Orlandi, S. Strazzari, C. Puggioli, A. Battistini, G. Bacci, Serum methotrexate (MTX) concentrations and prognosis in patients with osteosarcoma of the extremities treated with a multidrug neoadjuvant regimen. Journal of Chemotherapy. ,vol. 5, pp. 135- 141 ,(1993) , 10.1080/1120009X.1993.11739222
Pratt Cb, Jaffe N, Epelman S, Bleomycin, cyclophosphamide, and dactinomycin in metastatic osteosarcoma: lack of tumor regression in previously treated patients. Cancer treatment reports. ,vol. 71, pp. 421- 423 ,(1987)
William H. Meyer, Charles B. Pratt, Catherine A. Poquette, Bhaskar N. Rao, David M. Parham, Neyssa M. Marina, Alberto S. Pappo, Hazem H. Mahmoud, Jesse J. Jenkins, James Harper, Michael Neel, Barry D. Fletcher, Carboplatin/Ifosfamide Window Therapy for Osteosarcoma: Results of the St Jude Children’s Research Hospital OS-91 Trial Journal of Clinical Oncology. ,vol. 19, pp. 171- 182 ,(2001) , 10.1200/JCO.2001.19.1.171
N Graf, K Winkler, M Betlemovic, N Fuchs, U Bode, Methotrexate pharmacokinetics and prognosis in osteosarcoma. Journal of Clinical Oncology. ,vol. 12, pp. 1443- 1451 ,(1994) , 10.1200/JCO.1994.12.7.1443
W G Ward, K Mikaelian, F Dorey, J M Mirra, A Sassoon, E C Holmes, F R Eilber, J J Eckardt, Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. Journal of Clinical Oncology. ,vol. 12, pp. 1849- 1858 ,(1994) , 10.1200/JCO.1994.12.9.1849
A M Goorin, M J Delorey, E E Lack, R D Gelber, K Price, J R Cassady, R Levey, D Tapper, N Jaffe, M Link, Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: analysis of 32 patients. Journal of Clinical Oncology. ,vol. 2, pp. 425- 431 ,(1984) , 10.1200/JCO.1984.2.5.425
P Picci, L Sangiorgi, B T Rougraff, J R Neff, R Casadei, M Campanacci, Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. Journal of Clinical Oncology. ,vol. 12, pp. 2699- 2705 ,(1994) , 10.1200/JCO.1994.12.12.2699
P A Meyers, R Gorlick, G Heller, E Casper, J Lane, A G Huvos, J H Healey, Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. Journal of Clinical Oncology. ,vol. 16, pp. 2452- 2458 ,(1998) , 10.1200/JCO.1998.16.7.2452
P A Meyers, G Heller, J H Healey, A Huvos, A Applewhite, M Sun, M LaQuaglia, Osteogenic sarcoma with clinically detectable metastasis at initial presentation. Journal of Clinical Oncology. ,vol. 11, pp. 449- 453 ,(1993) , 10.1200/JCO.1993.11.3.449
S I Bearman, F R Appelbaum, C D Buckner, F B Petersen, L D Fisher, R A Clift, E D Thomas, Regimen-related toxicity in patients undergoing bone marrow transplantation. Journal of Clinical Oncology. ,vol. 6, pp. 1562- 1568 ,(1988) , 10.1200/JCO.1988.6.10.1562